Hemler M E, Malissen B, Rebai N, Liabeuf A, Mawas C, Kourilsky F M, Strominger J L
Hum Immunol. 1983 Oct;8(2):153-65. doi: 10.1016/0198-8859(83)90010-1.
A T cell growth factor-dependent alloreactive human T cell line has been used to generate a monoclonal antibody B1.49.9 that reacts with an antigen present on most if not all mitogen or alloantigen activated T cells but not on resting T cells. The T lymphoblastoid cell line HUT-102 is also strongly reactive with B1.49.9 but all other T and non-T leukemia-lymphoma cell lines tested were negative. The B1.49.9 antigen is a glycoprotein of 55,000 Mr on mitogen or alloantigen activated T cells and 50,000 Mr on the cell line HUT-102. Pulse labeling experiments showed that a 40,000 Mr precursor (at approximately 0.7 h) which does not bind to ricin lectin precedes the appearance of the ricin-binding 55,000 Mr form. Comparisons of the monoclonal antibody anti-Tac, which recognizes the IL-2 receptor, to B1.49.9 suggest that B1.49.9 also recognizes a structure similar or identical to the IL-2 receptor.
一种依赖T细胞生长因子的同种异体反应性人T细胞系已被用于产生单克隆抗体B1.49.9,该抗体可与大多数(如果不是全部)有丝分裂原或同种异体抗原激活的T细胞上存在的一种抗原发生反应,但与静止T细胞上的抗原不发生反应。T淋巴母细胞系HUT-102也与B1.49.9有强烈反应,但测试的所有其他T和非T白血病-淋巴瘤细胞系均为阴性。B1.49.9抗原在有丝分裂原或同种异体抗原激活的T细胞上是一种55,000道尔顿的糖蛋白,在细胞系HUT-102上是50,000道尔顿。脉冲标记实验表明,在与蓖麻凝集素结合的55,000道尔顿形式出现之前,有一种不与蓖麻凝集素结合的40,000道尔顿前体(约在0.7小时)。将识别IL-2受体的单克隆抗体抗Tac与B1.49.9进行比较表明,B1.49.9也识别与IL-2受体相似或相同的结构。